Biocon Biologics joins hands with IDF
Biocon Biologics has partnered with The International Diabetes Federation (IDF) as the first biosimilar insulin company to promote and support IDF’s Core Mission initiative and activities.
This important partnership with IDF coincides with the start of the centenary celebrations of the discovery of insulin and takes forward Biocon Biologics’ mission of enabling affordable access to insulins to people with diabetes worldwide.
Nearly a century after the discovery of insulin, millions of people with diabetes are denied regular and affordable access to this life-saving therapy. People with diabetes are not just finding it difficult to access insulin in emerging markets, even those in developed markets like US are finding it difficult to afford insulin therapy. As a credible, global insulins player, having served more than two billion doses of human insulin till date, Biocon Biologics has been engaging with key stakeholders at various global forums to find ways to increase affordable access to insulin and ensure the therapy reaches those who need them the most.
Dr Alexander Zach, Global Head of Market Access & Policy, Biocon Biologics, said, “We are delighted to partner with the International Diabetes Federation and contribute to a stronger global voice for people living with diabetes. Despite 100 years since its discovery, a key impediment to successful diabetes treatment with insulins is the lack of equitable access to affordable insulins. As a leading global insulins player, we have a shared vision of finding viable, long-term solutions to improve insulin access and affordability. This partnership with IDF will further propel these efforts to realise the company’s aspiration of reaching ‘one in five’ insulin-dependent people with diabetes globally. Given our extensive experience in providing affordable insulins globally, we believe we can contribute and support IDF in driving real policy and access actions that will transform lives and diabetes care.”
Read More:- https://techpeindia.com/pharma/biocon-biologics-joins-hands-with-idf/2467/